Author

Siti V. Fransiska

PT Bio Farma (Indonesia)ORCID 0009-0007-6768-8232Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Acep Riza WijayadikusumahiD· 1 shared Afrillia Nuryanti GarmanaiD· 1 shared Astria Novitasari NidomiD· 1 shared Chairul Anwar NidomiD· 1 shared Darsono Darsono· 1 shared Dhyan K. Ayuningtyas· 1 shared Elin Yulinah· 1 shared Gembong S. Nugroho· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Acep Riza WijayadikusumahORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintDec 18, 2024

Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus

Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari…·Chairul Anwar Nidom

This study evaluates the immunogenicity, efficacy, and safety of a recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in various animal models, showing significant antibody responses and protection against infection.

DOI 10.1101/2024.12.18.629000

mousenon-human primate

𝕏 PostBluesky